Do analysts rate QTEX or KEQU?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, QTEX or KEQU?

Kewaunee Scientific has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 101.45 -$13.22M N/A N/A Kewaunee Scientific $282M 0.35 $9.62M $3.22 10.72

Do analysts prefer LNSR or QTEX?

LENSAR presently has a consensus target price of $11.50, suggesting a potential upside of 42.86%. Given LENSAR's stronger consensus rating and higher possible upside, equities research analysts plainly believe LENSAR is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LENSAR 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, LNSR or QTEX?

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than LENSAR. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LENSAR $58.44M 1.69 -$34.28M -$0.33 N/A Inspira Technologies OXY B.H.N. $290K 101.45 -$13.22M N/A N/A

Do analysts prefer QTEX or MBOT?

Microbot Medical has a consensus target price of $6.38, indicating a potential upside of 336.64%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts plainly believe Microbot Medical is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Microbot Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has preferable valuation and earnings, QTEX or MBOT?

Microbot Medical has lower revenue, but higher earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 101.45 -$13.22M N/A N/A Microbot Medical N/A N/A -$13.14M -$0.24 N/A

Is QTEX or MBOT more profitable?

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Microbot Medical's return on equity. Company Net Margins Return on Equity Return on Assets Inspira Technologies OXY B.H.N. N/A N/A N/A Microbot Medical N/A -21.87% -20.76%

Do analysts recommend QTEX or LUNG?

Pulmonx has a consensus price target of $7.67, indicating a potential upside of 314.41%. Given Pulmonx's stronger consensus rating and higher possible upside, analysts plainly believe Pulmonx is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Pulmonx 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has better earnings and valuation, QTEX or LUNG?

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Pulmonx. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 101.45 -$13.22M N/A N/A Pulmonx $90.50M 0.88 -$54M -$1.16 N/A

Do analysts recommend QTEX or RNXT?

RenovoRx has a consensus price target of $8.50, indicating a potential upside of 380.23%. Given RenovoRx's stronger consensus rating and higher probable upside, analysts plainly believe RenovoRx is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 RenovoRx 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75

Which has better earnings & valuation, QTEX or RNXT?

RenovoRx has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 101.45 -$13.22M N/A N/A RenovoRx $1.12M 71.32 -$11.17M -$0.31 N/A

Inspira Technologies OXY B.H.N. (QTEX) Competitors

$0.82 -0.01 (-0.87%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$0.83 +0.01 (+1.54%)

As of 06:35 AM Eastern

Compare

QTEX vs. KEQU, LNSR, MBOT, LUNG, and RNXT

Should you buy Inspira Technologies OXY B.H.N. stock or one of its competitors? Inspira Technologies OXY B.H.N.'s main competitors and comparable companies include Kewaunee Scientific (KEQU), LENSAR (LNSR), Microbot Medical (MBOT), Pulmonx (LUNG), and RenovoRx (RNXT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to Kewaunee Scientific?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

Kewaunee Scientific has a net margin of 2.97% compared to Inspira Technologies OXY B.H.N.'s net margin of 0.00%. Kewaunee Scientific's return on equity of 11.75% beat Inspira Technologies OXY B.H.N.'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Kewaunee Scientific	2.97%	11.75%	4.78%

Inspira Technologies OXY B.H.N. has a beta of 4.24, meaning that its share price is 324% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.73, meaning that its share price is 27% less volatile than the broader market.

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Kewaunee Scientific has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	101.45	-$13.22M	N/A	N/A
Kewaunee Scientific	$282M	0.35	$9.62M	$3.22	10.72

In the previous week, Kewaunee Scientific had 6 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 7 mentions for Kewaunee Scientific and 1 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 1.89 beat Kewaunee Scientific's score of 0.87 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Overall Sentiment
Inspira Technologies OXY B.H.N.	Very Positive
Kewaunee Scientific	Positive

Summary

Kewaunee Scientific beats Inspira Technologies OXY B.H.N. on 8 of the 12 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to LENSAR?

LENSAR (NASDAQ:LNSR) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than LENSAR.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LENSAR	$58.44M	1.69	-$34.28M	-$0.33	N/A
Inspira Technologies OXY B.H.N.	$290K	101.45	-$13.22M	N/A	N/A

In the previous week, LENSAR had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for LENSAR and 1 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 1.89 beat LENSAR's score of 1.84 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the news media.

Company	Overall Sentiment
LENSAR	Very Positive
Inspira Technologies OXY B.H.N.	Very Positive

LENSAR has a net margin of 57.57% compared to Inspira Technologies OXY B.H.N.'s net margin of 0.00%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat LENSAR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LENSAR	57.57%	-529.08%	50.03%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

LENSAR has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.24, indicating that its stock price is 324% more volatile than the broader market.

LENSAR presently has a consensus target price of $11.50, suggesting a potential upside of 42.86%. Given LENSAR's stronger consensus rating and higher possible upside, equities research analysts plainly believe LENSAR is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

40.2% of LENSAR shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 65.8% of LENSAR shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

LENSAR beats Inspira Technologies OXY B.H.N. on 9 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Microbot Medical?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

Microbot Medical has a consensus target price of $6.38, indicating a potential upside of 336.64%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts plainly believe Microbot Medical is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Microbot Medical	N/A	-21.87%	-20.76%

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Comparatively, 4.7% of Microbot Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Inspira Technologies OXY B.H.N. has a beta of 4.24, indicating that its share price is 324% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market.

Microbot Medical has lower revenue, but higher earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	101.45	-$13.22M	N/A	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.24	N/A

In the previous week, Microbot Medical had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for Microbot Medical and 1 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 1.89 beat Microbot Medical's score of 1.70 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Overall Sentiment
Inspira Technologies OXY B.H.N.	Very Positive
Microbot Medical	Very Positive

Summary

Inspira Technologies OXY B.H.N. and Microbot Medical tied by winning 6 of the 12 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Pulmonx?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Pulmonx (NASDAQ:LUNG) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Inspira Technologies OXY B.H.N. has a beta of 4.24, indicating that its share price is 324% more volatile than the broader market. Comparatively, Pulmonx has a beta of 0.34, indicating that its share price is 66% less volatile than the broader market.

In the previous week, Pulmonx had 2 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 3 mentions for Pulmonx and 1 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 1.89 beat Pulmonx's score of 0.66 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Overall Sentiment
Inspira Technologies OXY B.H.N.	Very Positive
Pulmonx	Positive

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 91.0% of Pulmonx shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 7.5% of Pulmonx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Pulmonx's net margin of -55.03%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Pulmonx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Pulmonx	-55.03%	-96.66%	-38.32%

Pulmonx has a consensus price target of $7.67, indicating a potential upside of 314.41%. Given Pulmonx's stronger consensus rating and higher possible upside, analysts plainly believe Pulmonx is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pulmonx	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Pulmonx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	101.45	-$13.22M	N/A	N/A
Pulmonx	$90.50M	0.88	-$54M	-$1.16	N/A

Summary

Inspira Technologies OXY B.H.N. beats Pulmonx on 8 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to RenovoRx?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and RenovoRx (NASDAQ:RNXT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment.

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 3.1% of RenovoRx shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 9.4% of RenovoRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, RenovoRx had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for RenovoRx and 1 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 1.89 beat RenovoRx's score of 1.23 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Overall Sentiment
Inspira Technologies OXY B.H.N.	Very Positive
RenovoRx	Positive

RenovoRx has a consensus price target of $8.50, indicating a potential upside of 380.23%. Given RenovoRx's stronger consensus rating and higher probable upside, analysts plainly believe RenovoRx is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
RenovoRx	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

RenovoRx has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	101.45	-$13.22M	N/A	N/A
RenovoRx	$1.12M	71.32	-$11.17M	-$0.31	N/A

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to RenovoRx's net margin of -621.71%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat RenovoRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
RenovoRx	-621.71%	-135.11%	-101.91%

Inspira Technologies OXY B.H.N. has a beta of 4.24, suggesting that its share price is 324% more volatile than the broader market. Comparatively, RenovoRx has a beta of 1.12, suggesting that its share price is 12% more volatile than the broader market.

Summary

Inspira Technologies OXY B.H.N. beats RenovoRx on 8 of the 15 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QTEX vs. The Competition

Export

Metric	Inspira Technologies OXY B.H.N.	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$29.68M	$5.58B	$7.21B	$12.81B
Dividend Yield	N/A	1.78%	2.56%	10.55%
P/E Ratio	N/A	24.44	272.83	25.11
Price / Sales	101.45	72.50	623.31	90.53
Price / Cash	N/A	32.69	77.33	51.83
Price / Book	13.64	5.89	10.38	6.18
Net Income	-$13.22M	$150.94M	$3.49B	$358.18M
7 Day Performance	-1.81%	-3.04%	-3.16%	-2.51%
1 Month Performance	-17.82%	-3.90%	0.02%	-2.73%
1 Year Performance	N/A	5.59%	17.32%	7.73%

Inspira Technologies OXY B.H.N. Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QTEX Inspira Technologies OXY B.H.N.	0.5846 of 5 stars	$0.82 -0.9%	N/A	N/A	$29.68M	$290K	N/A	20	Positive News
KEQU Kewaunee Scientific	0.7852 of 5 stars	$36.31 -3.6%	N/A	-36.9%	$108.06M	$282M	11.28	1,231	Earnings Report Gap Down High Trading Volume
LNSR LENSAR	3.3237 of 5 stars	$8.50 +0.5%	$11.50 +35.3%	-33.6%	$103.94M	$58.44M	N/A	110	Positive News
MBOT Microbot Medical	2.1037 of 5 stars	$1.46 -0.7%	$6.38 +336.6%	-59.1%	$98.73M	$346K	N/A	20	Positive News
LUNG Pulmonx	3.2614 of 5 stars	$2.28 +1.8%	$7.67 +236.3%	+14.9%	$96.20M	$90.50M	N/A	250

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QTEX) was last updated on 9/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inspira Technologies OXY B.H.N. (QTEX) Competitors

QTEX vs. KEQU, LNSR, MBOT, LUNG, and RNXT

How does Inspira Technologies OXY B.H.N. compare to Kewaunee Scientific?

Summary

How does Inspira Technologies OXY B.H.N. compare to LENSAR?

Summary

How does Inspira Technologies OXY B.H.N. compare to Microbot Medical?

Summary

How does Inspira Technologies OXY B.H.N. compare to Pulmonx?

Summary

How does Inspira Technologies OXY B.H.N. compare to RenovoRx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTEX vs. The Competition

Inspira Technologies OXY B.H.N. Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Inspira Technologies OXY B.H.N. (QTEX) Competitors

QTEX vs. KEQU, LNSR, MBOT, LUNG, and RNXT

How does Inspira Technologies OXY B.H.N. compare to Kewaunee Scientific?

Is QTEX or KEQU more profitable?

Which has more volatility & risk, QTEX or KEQU?

Do insiders & institutionals have more ownership in QTEX or KEQU?

Do analysts rate QTEX or KEQU?

Which has better earnings & valuation, QTEX or KEQU?

Does the media prefer QTEX or KEQU?

Summary

How does Inspira Technologies OXY B.H.N. compare to LENSAR?

Which has better valuation and earnings, LNSR or QTEX?

Does the media prefer LNSR or QTEX?

Is LNSR or QTEX more profitable?

Which has more volatility & risk, LNSR or QTEX?

Do analysts prefer LNSR or QTEX?

Do insiders and institutionals have more ownership in LNSR or QTEX?

Summary

How does Inspira Technologies OXY B.H.N. compare to Microbot Medical?

Do analysts prefer QTEX or MBOT?

Is QTEX or MBOT more profitable?

Do insiders & institutionals hold more shares of QTEX or MBOT?

Which has more volatility and risk, QTEX or MBOT?

Which has preferable valuation and earnings, QTEX or MBOT?

Does the media prefer QTEX or MBOT?

Summary

How does Inspira Technologies OXY B.H.N. compare to Pulmonx?

Which has more risk and volatility, QTEX or LUNG?

Does the media favor QTEX or LUNG?

Do insiders and institutionals believe in QTEX or LUNG?

Is QTEX or LUNG more profitable?

Do analysts recommend QTEX or LUNG?

Which has better earnings and valuation, QTEX or LUNG?

Summary

How does Inspira Technologies OXY B.H.N. compare to RenovoRx?

Do institutionals and insiders hold more shares of QTEX or RNXT?

Does the media prefer QTEX or RNXT?

Do analysts recommend QTEX or RNXT?

Which has better earnings & valuation, QTEX or RNXT?

Is QTEX or RNXT more profitable?

Which has more volatility & risk, QTEX or RNXT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTEX vs. The Competition

Inspira Technologies OXY B.H.N. Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools